Cargando…

A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis

Hypertriglyceridemia is a common disease with only 2% of cases exhibiting monogenic mutations. Familial chylomicronemia syndrome (FCS) is a rare genetic condition associated with recurrent and severe episodes of pancreatitis and is mainly caused by mutations in the LPL gene, with few cases related t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinilla-Monsalve, Gabriel D, Lores, Juliana, Pachajoa, Harry, López-Ponce de León, Juan D, López, Alejandro, Rodríguez-Rojas, Lisa X, Nastasi-Catanese, José A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125404/
https://www.ncbi.nlm.nih.gov/pubmed/32280258
http://dx.doi.org/10.2147/TACG.S243148
_version_ 1783515937007206400
author Pinilla-Monsalve, Gabriel D
Lores, Juliana
Pachajoa, Harry
López-Ponce de León, Juan D
López, Alejandro
Rodríguez-Rojas, Lisa X
Nastasi-Catanese, José A
author_facet Pinilla-Monsalve, Gabriel D
Lores, Juliana
Pachajoa, Harry
López-Ponce de León, Juan D
López, Alejandro
Rodríguez-Rojas, Lisa X
Nastasi-Catanese, José A
author_sort Pinilla-Monsalve, Gabriel D
collection PubMed
description Hypertriglyceridemia is a common disease with only 2% of cases exhibiting monogenic mutations. Familial chylomicronemia syndrome (FCS) is a rare genetic condition associated with recurrent and severe episodes of pancreatitis and is mainly caused by mutations in the LPL gene, with few cases related to abnormal function of apolipoprotein C-II. This is a 50-year-old female with a past medical history of arterial hypertension, miscarriage and recurrent pancreatitis. In the last four years, her triglycerides and lipase concentration reached >3000 mg/dL and >700 U/L, respectively. The patient was not responsive to statins, fibrates, or tetrahydrolipstatin. A novel homozygous frameshift mutation on exon 3 of the APOC2 gene was detected, c.133_134delTC. Subsequent Sanger sequencing confirmed that three first-degree relatives were carriers of the same mutation. To the best of our knowledge, we are reporting the first Colombian patient with FCS due to an APOC2 mutation. We propose that this mutation caused recurrent hypertriglyceridemic pancreatitis.
format Online
Article
Text
id pubmed-7125404
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-71254042020-04-10 A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis Pinilla-Monsalve, Gabriel D Lores, Juliana Pachajoa, Harry López-Ponce de León, Juan D López, Alejandro Rodríguez-Rojas, Lisa X Nastasi-Catanese, José A Appl Clin Genet Case Report Hypertriglyceridemia is a common disease with only 2% of cases exhibiting monogenic mutations. Familial chylomicronemia syndrome (FCS) is a rare genetic condition associated with recurrent and severe episodes of pancreatitis and is mainly caused by mutations in the LPL gene, with few cases related to abnormal function of apolipoprotein C-II. This is a 50-year-old female with a past medical history of arterial hypertension, miscarriage and recurrent pancreatitis. In the last four years, her triglycerides and lipase concentration reached >3000 mg/dL and >700 U/L, respectively. The patient was not responsive to statins, fibrates, or tetrahydrolipstatin. A novel homozygous frameshift mutation on exon 3 of the APOC2 gene was detected, c.133_134delTC. Subsequent Sanger sequencing confirmed that three first-degree relatives were carriers of the same mutation. To the best of our knowledge, we are reporting the first Colombian patient with FCS due to an APOC2 mutation. We propose that this mutation caused recurrent hypertriglyceridemic pancreatitis. Dove 2020-03-26 /pmc/articles/PMC7125404/ /pubmed/32280258 http://dx.doi.org/10.2147/TACG.S243148 Text en © 2020 Pinilla-Monsalve et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Pinilla-Monsalve, Gabriel D
Lores, Juliana
Pachajoa, Harry
López-Ponce de León, Juan D
López, Alejandro
Rodríguez-Rojas, Lisa X
Nastasi-Catanese, José A
A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis
title A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis
title_full A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis
title_fullStr A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis
title_full_unstemmed A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis
title_short A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis
title_sort novel apoc2 mutation in a colombian patient with recurrent hypertriglyceridemic pancreatitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125404/
https://www.ncbi.nlm.nih.gov/pubmed/32280258
http://dx.doi.org/10.2147/TACG.S243148
work_keys_str_mv AT pinillamonsalvegabrield anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT loresjuliana anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT pachajoaharry anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT lopezponcedeleonjuand anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT lopezalejandro anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT rodriguezrojaslisax anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT nastasicatanesejosea anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT pinillamonsalvegabrield novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT loresjuliana novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT pachajoaharry novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT lopezponcedeleonjuand novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT lopezalejandro novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT rodriguezrojaslisax novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis
AT nastasicatanesejosea novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis